Recently we reported m1A impedes tRF-3 gene-silencing activity and is over-expressed in BLCA tumor, coinciding with over-expression of the writer enzyme proteins TRMT6/61A and dysregulation of the tRF-3 targetome (Su et al., 2022). The gene discussed is TBPL2; the disease is bladder transitional cell carcinoma.